Rebif Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection
Condition:   AsthmaInterventions:   Drug: Interferon beta-1a Nebuliser solution 48 μg/mL;   Drug: PlaceboSponsor:   AstraZenecaNot yet recruiting - verified July 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 16, 2015 Category: Research Source Type: clinical trials

Study of Efficacy and Safety of Drugs BCD-033 and Rebif for Treatment of Patients With Multiple Sclerosis
Condition:   Multiple SclerosisInterventions:   Drug: BCD-033 (interferon beta 1b);   Drug: Rebif (interferon beta 1b);   Drug: PlaceboSponsor:   BiocadActive, not recruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 29, 2015 Category: Research Source Type: clinical trials